๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

171 Strategy to augment the efficacy of immunotherapy for refractory breast cancer: a pilot clinical study of adoptive cell therapy combined with trastuzumab

โœ Scribed by N. Seki; U. Toh; T. Fujii; S. Nakagawa; H. Otsuka; K. Shirouzu; H. Yamana

Book ID
119601188
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
64 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Clinical outcomes in patients who receiv
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology
โœ Kaplan, Muhammet Ali; Isikdogan, Abdurrahman; Koca, DoฤŸan; Kucukoner, Mehmet; Gu ๐Ÿ“‚ Article ๐Ÿ“… 2013 ๐Ÿ› Springer Japan ๐ŸŒ English โš– 245 KB
53 POSTER A phase II, multicenter, rando
53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastinยฎ) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarcevaยฎ) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer
โœ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 59 KB